乐播传媒

In a study published July 6 CU Boulder researchers come one step closer to answering that fundamental question, concluding that the molecular messenger RNA (ribonucleic acid) plays an indispensable role in cell differentiation, serving as a bridge between our genes and the so-called 鈥渆pigenetic鈥� machinery that turns them on and off.

Researchers at CU Boulder, led by Biochemistry Professor Robert Batey , have developed compositions and methods for temporal regulation of single guide RNAs (sgRNAs) that comprise a small molecule-binding aptamer in the sgRNA, which enables small-molecule-dependent gene editing in bacteria. They also developed a method for selecting sgRNAs that are...

Scientists have been studying cyanobacteria and its many potential applications for decades, from cutting CO2 emissions to creating a substitute for oil-based plastics, but there wasn鈥檛 a deep understanding of the full life cycle and metabolism of specialized compartments within these common bacteria 鈥� until now.

When do cells decide to divide? For 40 years, the textbook answer has been that this decision occurs in the first phase of a cell鈥檚 existence 鈥� right after a mother cell divides to become daughter cells. But researchers at CU Boulder have found that it鈥檚 actually the mother cell...

In a study published today, a team at CU Boulder took advantage of a new microscopic technique to follow the lives of individual bacteria as they grew and divided in complex colonies.

CU Boulder researchers have developed a new approach to designing more sustainable buildings with help from some of the tiniest contractors out there.

Researchers have discovered the structure of the FACT protein鈥攁 mysterious protein central to the functioning of DNA

Lab Venture Challenge awards $900,000 to promising bioscience, physical science and engineering ventures

Telomerase reverse transcriptase (TERT), an enzyme associated with nearly all malignant human cancers, is even more diverse and unconventional than previously realized according to new research by CU Biochem and BioFrontiers' Distinguished Professor Thomas Cech and Professor John Rinn.

CU Boulder and Howard Hughes Medical Institute (HHMI) biochemists have revealed a key regulatory process in a gene-suppressing protein group that could hold future applications for drug discovery and clinical treatment of diseases, including cancer.